Kyverna Therapeutics, Inc. KYTX Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Kyverna Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kyverna Therapeutics, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kyverna Therapeutics, Inc.'s software and technology licenses, net?
- Kyverna Therapeutics, Inc. (KYTX) reported software and technology licenses, net of $5.01M in Q1 2026.
- How has Kyverna Therapeutics, Inc.'s software and technology licenses, net changed year-over-year?
- Kyverna Therapeutics, Inc.'s software and technology licenses, net increased by 37.6% year-over-year, from $3.64M to $5.01M.
- What is the long-term trend for Kyverna Therapeutics, Inc.'s software and technology licenses, net?
- Over 2 years (2023 to 2025), Kyverna Therapeutics, Inc.'s software and technology licenses, net has grown at a 20.9% compound annual growth rate (CAGR), from $3.36M to $4.9M.